Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry

Analytical Biochemistry

Volumn 395, Issue 1, 2009, Pages 116-118

  Wildsmith, Kristin R ^a   Han, Bomie ^b   Bateman, Randall J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEINS; PEPTIDES; SILT;

ANALYSIS METHOD; APOLIPOPROTEIN E; APOLIPOPROTEIN E (APOE); MODEL PROTEINS; RELATIVE QUANTITATIONS; SIMULTANEOUS DETECTION; STABLE-ISOTOPE LABELING; TANDEM MASS SPECTROMETRY;

MASS SPECTROMETRY;

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CARBON 13;

ADSORPTION; ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASTROCYTES; CARBON ISOTOPES; CELL LINE, TRANSFORMED; GENE KNOCK-IN TECHNIQUES; INDICATOR DILUTION TECHNIQUES; LIPOPROTEINS; MICE; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; RISK FACTORS; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 70349154194     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.07.049     Document Type: Article

References (18)

1. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell Jr. P.C., Rimmler J.B., Locke P.A., Conneally P.M., and Schmader K.E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7 (1994) 180-184
2. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997) 1349-1356
3. Fukumoto H., Ingelsson M., Garevik N., Wahlund L.O., Nukina N., Yaguchi Y., Shibata M., Hyman B.T., Rebeck G.W., and Irizarry M.C. APOE epsilon 3/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis [see comment]. Exp. Neurol. 183 (2003) 249-253
4. Riddell D.R., Zhou H., Atchison K., Warwick H.K., Atkinson P.J., Jefferson J., Xu L., Aschmies S., Kirksey Y., Hu Y., Wagner E., Parratt A., Xu J., Li Z., Zaleska M.M., Jacobsen J.S., Pangalos M.N., and Reinhart P.H. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 28 (2008) 11445-11453
5. Bateman R.J., Munsell L.Y., Chen X., Holtzman D.M., and Yarasheski K.E. Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates. J. Am. Soc. Mass Spectrom. 18 (2007) 997-1006
6. Elbert D.L., Mawuenyega K.G., Scott E.A., Wildsmith K.R., and Bateman R.J. Stable isotope labeling tandem mass spectrometry (SILT): integration with peptide identification and extension to data-dependent scans. J. Proteome Res. 7 (2008) 4546-4556
7. Bateman R.J., Munsell L.Y., Morris J.C., Swarm R., Yarasheski K.E., and Holtzman D.M. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat. Med. 12 (2006) 856-861
8. Bateman R.J., Siemers E.R., Mawuenyega K.G., Wen G., Browning K.R., Sigurdson W.C., Yarasheski K.E., Friedrich S.W., Demattos R.B., May P.C., Paul S.M., and Holtzman D.M. A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system. Ann. Neurol. 66 (2009) 48-54
9. Morikawa M., Fryer J.D., Sullivan P.M., Christopher E.A., Wahrle S.E., DeMattos R.B., O'Dell M.A., Fagan A.M., Lashuel H.A., Walz T., Asai K., and Holtzman D.M. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta. Neurobiol. Dis. 19 (2005) 66-76
10. Mann M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7 (2006) 952-958
11. Doherty K., Whitehead C., McCormack H., Gaskell S.J., and Beynon R.J. Proteome dynamics in complex organisms: using stable isotopes to monitor individual protein turnover rates. Proteomics 5 (2005) 522-533
12. McClatchy D.B., Dong M.Q., Wu C.C., Venable J.D., and Yates III J.R. 15N metabolic labeling of mammalian tissue with slow protein turnover. J. Proteome Res. 6 (2007) 2005-2010
13. Molina H., Parmigiani G., and Pandey A. Assessing reproducibility of a protein dynamics study using in vivo labeling and liquid chromatography tandem mass spectrometry. Anal. Chem. 77 (2005) 2739-2744
14. Patterson B.W., Hachey D.L., Cook G.L., Amann J.M., and Klein P.D. Incorporation of a stable isotopically labeled amino acid into multiple human apolipoproteins. J. Lipid Res. 32 (1991) 1063-1072
15. Sato T., Ishihama Y., and Oda Y. Quantitative proteomics of mouse brain and specific protein-interaction studies using stable isotope labeling. Methods Mol. Biol. 359 (2007) 53-70
16. Wolfe R.R., Chinkes D.L., and Wolfe R.R. Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis (2005), Wiley-Liss, Hoboken, NJ
17. Dinkel R.E., Barrett P.H., Demant T., and Parhofer K.G. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects. Nutr. Metab. Cardiovasc. Dis. 16 (2006) 215-221
18. Hatters D.M., Peters-Libeu C.A., and Weisgraber K.H. Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 31 (2006) 445-454